Global Stem Cell and Gene Therapy Biological Testing Market by Type (Cytotoxicity, Viability, Function, Cell Identification, Differentiation, Apoptosis, Isolation & Purification, Proliferation), by Induced Pluripotent Stem Cells (IPSCs), by Service (Services, Kits, Flow Cytometers, Cell Imaging Systems, Microelectrode Arrays, Automated Cell Counters), by Application (Orthopaedic & Musculoskeletal Spine Applications, Dermatology, Diabetes, Central Nervous System Applications, Cardiovascular Applications, Drug Discovery & Development, Clinical Research, Oncology), by Cell Type (Mesenchymal Stem Cells (Mesenchymal Stem Cells MSCs), by Neural Stem Cells (NSCs), by Human Embryonic Stem Cells (HESCs), by Hematopoietic Stem Cells (HSCs), by End User (Biopharmaceutical & Biotechnology Companies, Research Institute) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Stem Cell and Gene Therapy Biological Testing Market research report which is segmented by Type (Cytotoxicity, Viability, Function, Cell Identification, Differentiation, Apoptosis, Isolation & Purification, Proliferation), by Induced Pluripotent Stem Cells (IPSCs), by Service (Services, Kits, Flow Cytometers, Cell Imaging Systems, Microelectrode Arrays, Automated Cell Counters), by Application (Orthopaedic & Musculoskeletal Spine Applications, Dermatology, Diabetes, Central Nervous System Applications, Cardiovascular Applications, Drug Discovery & Development, Clinical Research, Oncology), by Cell Type (Mesenchymal Stem Cells (Mesenchymal Stem Cells MSCs), by Neural Stem Cells (NSCs), by Human Embryonic Stem Cells (HESCs), by Hematopoietic Stem Cells (HSCs), by End User (Biopharmaceutical & Biotechnology Companies, Research Institute), By Players/Companies Mesoblast Ltd, Anterogen Co. Ltd, AlloSource, Smith & Nephew, Promega Corporation, Osiris Therapeutics Inc, Thermo Fisher Scientific, GE Healthcare, Cellular Engineering Technologies, Pharmicell Ltd., Bio-Rad Laboratories, Merck”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Stem Cell and Gene Therapy Biological Testing Market Research Report |
| By Type | Cytotoxicity, Viability, Function, Cell Identification, Differentiation, Apoptosis, Isolation & Purification, Proliferation |
| By Induced Pluripotent Stem Cells | IPSCs |
| By Service | Services, Kits, Flow Cytometers, Cell Imaging Systems, Microelectrode Arrays, Automated Cell Counters |
| By Application | Orthopaedic & Musculoskeletal Spine Applications, Dermatology, Diabetes, Central Nervous System Applications, Cardiovascular Applications, Drug Discovery & Development, Clinical Research, Oncology |
| By Cell Type (Mesenchymal Stem Cells | Mesenchymal Stem Cells MSCs |
| By Neural Stem Cells | NSCs |
| By Human Embryonic Stem Cells | HESCs |
| By Hematopoietic Stem Cells | HSCs |
| By End User | Biopharmaceutical & Biotechnology Companies, Research Institute |
| By Companies | Mesoblast Ltd, Anterogen Co. Ltd, AlloSource, Smith & Nephew, Promega Corporation, Osiris Therapeutics Inc, Thermo Fisher Scientific, GE Healthcare, Cellular Engineering Technologies, Pharmicell Ltd., Bio-Rad Laboratories, Merck |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 214 |
| Number of Tables & Figures | 150 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Stem Cell and Gene Therapy Biological Testing Market Report Segments:
The market is segmented by Type (Cytotoxicity, Viability, Function, Cell Identification, Differentiation, Apoptosis, Isolation & Purification, Proliferation), by Induced Pluripotent Stem Cells (IPSCs), by Service (Services, Kits, Flow Cytometers, Cell Imaging Systems, Microelectrode Arrays, Automated Cell Counters), by Application (Orthopaedic & Musculoskeletal Spine Applications, Dermatology, Diabetes, Central Nervous System Applications, Cardiovascular Applications, Drug Discovery & Development, Clinical Research, Oncology), by Cell Type (Mesenchymal Stem Cells (Mesenchymal Stem Cells MSCs), by Neural Stem Cells (NSCs), by Human Embryonic Stem Cells (HESCs), by Hematopoietic Stem Cells (HSCs), by End User (Biopharmaceutical & Biotechnology Companies, Research Institute).
Some of the companies that are profiled in this report are:
- Mesoblast Ltd
- Anterogen Co. Ltd
- AlloSource
- Smith & Nephew
- Promega Corporation
- Osiris Therapeutics Inc
- Thermo Fisher Scientific
- GE Healthcare
- Cellular Engineering Technologies
- Pharmicell Ltd.
- Bio-Rad Laboratories
- Merck
Stem Cell and Gene Therapy Biological Testing Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Stem Cell and Gene Therapy Biological Testing Market
Overview of the regional outlook of the Stem Cell and Gene Therapy Biological Testing Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Stem Cell and Gene Therapy Biological Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Stem Cell and Gene Therapy Biological Testing Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Cytotoxicity
2. Viability
3. Function
4. Cell Identification
5. Differentiation
6. Apoptosis
7. Isolation & Purification
8. Proliferation
7. By Induced Pluripotent Stem Cells:1. IPSCs
8. By Service:1. Services
2. Kits
3. Flow Cytometers
4. Cell Imaging Systems
5. Microelectrode Arrays
6. Automated Cell Counters
9. By Application:1. Orthopaedic & Musculoskeletal Spine Applications
2. Dermatology
3. Diabetes
4. Central Nervous System Applications
5. Cardiovascular Applications
6. Drug Discovery & Development
7. Clinical Research
8. Oncology
10. By Cell Type (Mesenchymal Stem Cells:1. Mesenchymal Stem Cells MSCs
11. By Neural Stem Cells:1. NSCs
12. By Human Embryonic Stem Cells:1. HESCs
13. By Hematopoietic Stem Cells:1. HSCs
14. By End User:1. Biopharmaceutical & Biotechnology Companies
2. Research Institute
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell and Gene Therapy Biological Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Stem Cell and Gene Therapy Biological Testing Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stem Cell and Gene Therapy Biological Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stem Cell and Gene Therapy Biological Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stem Cell and Gene Therapy Biological Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stem Cell and Gene Therapy Biological Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stem Cell and Gene Therapy Biological Testing Market Size & Forecast, 2018-2028
4.5.1 Stem Cell and Gene Therapy Biological Testing Market Size and Y-o-Y Growth
4.5.2 Stem Cell and Gene Therapy Biological Testing Market Absolute $ Opportunity
Chapter 5 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
5.2.1 Cytotoxicity
5.2.2 Viability
5.2.3 Function
5.2.4 Cell Identification
5.2.5 Differentiation
5.2.6 Apoptosis
5.2.7 Isolation & Purification
5.2.8 Proliferation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Induced Pluripotent Stem Cells
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Induced Pluripotent Stem Cells
6.1.2 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
6.1.3 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
6.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
6.2.1 IPSCs
6.3 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
Chapter 7 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Service
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Service
7.1.2 Basis Point Share (BPS) Analysis by Service
7.1.3 Absolute $ Opportunity Assessment by Service
7.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
7.2.1 Services
7.2.2 Kits
7.2.3 Flow Cytometers
7.2.4 Cell Imaging Systems
7.2.5 Microelectrode Arrays
7.2.6 Automated Cell Counters
7.3 Market Attractiveness Analysis by Service
Chapter 8 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Application
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Application
8.1.2 Basis Point Share (BPS) Analysis by Application
8.1.3 Absolute $ Opportunity Assessment by Application
8.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
8.2.1 Orthopaedic & Musculoskeletal Spine Applications
8.2.2 Dermatology
8.2.3 Diabetes
8.2.4 Central Nervous System Applications
8.2.5 Cardiovascular Applications
8.2.6 Drug Discovery & Development
8.2.7 Clinical Research
8.2.8 Oncology
8.3 Market Attractiveness Analysis by Application
Chapter 9 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Cell Type (Mesenchymal Stem Cells
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Cell Type (Mesenchymal Stem Cells
9.1.2 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
9.1.3 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
9.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
9.2.1 Mesenchymal Stem Cells MSCs
9.3 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
Chapter 10 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Neural Stem Cells
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by Neural Stem Cells
10.1.2 Basis Point Share (BPS) Analysis by Neural Stem Cells
10.1.3 Absolute $ Opportunity Assessment by Neural Stem Cells
10.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
10.2.1 NSCs
10.3 Market Attractiveness Analysis by Neural Stem Cells
Chapter 11 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Human Embryonic Stem Cells
11.1 Introduction
11.1.1 Key Market Trends & Growth Opportunities by Human Embryonic Stem Cells
11.1.2 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
11.1.3 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
11.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
11.2.1 HESCs
11.3 Market Attractiveness Analysis by Human Embryonic Stem Cells
Chapter 12 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Hematopoietic Stem Cells
12.1 Introduction
12.1.1 Key Market Trends & Growth Opportunities by Hematopoietic Stem Cells
12.1.2 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
12.1.3 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
12.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
12.2.1 HSCs
12.3 Market Attractiveness Analysis by Hematopoietic Stem Cells
Chapter 13 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by End User
13.1 Introduction
13.1.1 Key Market Trends & Growth Opportunities by End User
13.1.2 Basis Point Share (BPS) Analysis by End User
13.1.3 Absolute $ Opportunity Assessment by End User
13.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
13.2.1 Biopharmaceutical & Biotechnology Companies
13.2.2 Research Institute
13.3 Market Attractiveness Analysis by End User
Chapter 14 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Region
14.1 Introduction
14.1.1 Key Market Trends & Growth Opportunities by Region
14.1.2 Basis Point Share (BPS) Analysis by Region
14.1.3 Absolute $ Opportunity Assessment by Region
14.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Region
14.2.1 North America
14.2.2 Europe
14.2.3 Asia Pacific
14.2.4 Latin America
14.2.5 Middle East & Africa (MEA)
14.3 Market Attractiveness Analysis by Region
Chapter 15 Coronavirus Disease (COVID-19) Impact
15.1 Introduction
15.2 Current & Future Impact Analysis
15.3 Economic Impact Analysis
15.4 Government Policies
15.5 Investment Scenario
Chapter 16 North America Stem Cell and Gene Therapy Biological Testing Analysis and Forecast
16.1 Introduction
16.2 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Country
16.2.1 U.S.
16.2.2 Canada
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
16.6.1 Cytotoxicity
16.6.2 Viability
16.6.3 Function
16.6.4 Cell Identification
16.6.5 Differentiation
16.6.6 Apoptosis
16.6.7 Isolation & Purification
16.6.8 Proliferation
16.7 Basis Point Share (BPS) Analysis by Type
16.8 Absolute $ Opportunity Assessment by Type
16.9 Market Attractiveness Analysis by Type
16.10 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
16.10.1 IPSCs
16.11 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
16.12 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
16.13 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
16.14 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
16.14.1 Services
16.14.2 Kits
16.14.3 Flow Cytometers
16.14.4 Cell Imaging Systems
16.14.5 Microelectrode Arrays
16.14.6 Automated Cell Counters
16.15 Basis Point Share (BPS) Analysis by Service
16.16 Absolute $ Opportunity Assessment by Service
16.17 Market Attractiveness Analysis by Service
16.18 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
16.18.1 Orthopaedic & Musculoskeletal Spine Applications
16.18.2 Dermatology
16.18.3 Diabetes
16.18.4 Central Nervous System Applications
16.18.5 Cardiovascular Applications
16.18.6 Drug Discovery & Development
16.18.7 Clinical Research
16.18.8 Oncology
16.19 Basis Point Share (BPS) Analysis by Application
16.20 Absolute $ Opportunity Assessment by Application
16.21 Market Attractiveness Analysis by Application
16.22 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
16.22.1 Mesenchymal Stem Cells MSCs
16.23 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
16.24 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
16.25 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
16.26 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
16.26.1 NSCs
16.27 Basis Point Share (BPS) Analysis by Neural Stem Cells
16.28 Absolute $ Opportunity Assessment by Neural Stem Cells
16.29 Market Attractiveness Analysis by Neural Stem Cells
16.30 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
16.30.1 HESCs
16.31 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
16.32 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
16.33 Market Attractiveness Analysis by Human Embryonic Stem Cells
16.34 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
16.34.1 HSCs
16.35 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
16.36 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
16.37 Market Attractiveness Analysis by Hematopoietic Stem Cells
16.38 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
16.38.1 Biopharmaceutical & Biotechnology Companies
16.38.2 Research Institute
16.39 Basis Point Share (BPS) Analysis by End User
16.40 Absolute $ Opportunity Assessment by End User
16.41 Market Attractiveness Analysis by End User
Chapter 17 Europe Stem Cell and Gene Therapy Biological Testing Analysis and Forecast
17.1 Introduction
17.2 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Country
17.2.1 Germany
17.2.2 France
17.2.3 Italy
17.2.4 U.K.
17.2.5 Spain
17.2.6 Russia
17.2.7 Rest of Europe
17.3 Basis Point Share (BPS) Analysis by Country
17.4 Absolute $ Opportunity Assessment by Country
17.5 Market Attractiveness Analysis by Country
17.6 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
17.6.1 Cytotoxicity
17.6.2 Viability
17.6.3 Function
17.6.4 Cell Identification
17.6.5 Differentiation
17.6.6 Apoptosis
17.6.7 Isolation & Purification
17.6.8 Proliferation
17.7 Basis Point Share (BPS) Analysis by Type
17.8 Absolute $ Opportunity Assessment by Type
17.9 Market Attractiveness Analysis by Type
17.10 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
17.10.1 IPSCs
17.11 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
17.12 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
17.13 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
17.14 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
17.14.1 Services
17.14.2 Kits
17.14.3 Flow Cytometers
17.14.4 Cell Imaging Systems
17.14.5 Microelectrode Arrays
17.14.6 Automated Cell Counters
17.15 Basis Point Share (BPS) Analysis by Service
17.16 Absolute $ Opportunity Assessment by Service
17.17 Market Attractiveness Analysis by Service
17.18 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
17.18.1 Orthopaedic & Musculoskeletal Spine Applications
17.18.2 Dermatology
17.18.3 Diabetes
17.18.4 Central Nervous System Applications
17.18.5 Cardiovascular Applications
17.18.6 Drug Discovery & Development
17.18.7 Clinical Research
17.18.8 Oncology
17.19 Basis Point Share (BPS) Analysis by Application
17.20 Absolute $ Opportunity Assessment by Application
17.21 Market Attractiveness Analysis by Application
17.22 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
17.22.1 Mesenchymal Stem Cells MSCs
17.23 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
17.24 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
17.25 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
17.26 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
17.26.1 NSCs
17.27 Basis Point Share (BPS) Analysis by Neural Stem Cells
17.28 Absolute $ Opportunity Assessment by Neural Stem Cells
17.29 Market Attractiveness Analysis by Neural Stem Cells
17.30 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
17.30.1 HESCs
17.31 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
17.32 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
17.33 Market Attractiveness Analysis by Human Embryonic Stem Cells
17.34 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
17.34.1 HSCs
17.35 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
17.36 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
17.37 Market Attractiveness Analysis by Hematopoietic Stem Cells
17.38 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
17.38.1 Biopharmaceutical & Biotechnology Companies
17.38.2 Research Institute
17.39 Basis Point Share (BPS) Analysis by End User
17.40 Absolute $ Opportunity Assessment by End User
17.41 Market Attractiveness Analysis by End User
Chapter 18 Asia Pacific Stem Cell and Gene Therapy Biological Testing Analysis and Forecast
18.1 Introduction
18.2 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Country
18.2.1 China
18.2.2 Japan
18.2.3 South Korea
18.2.4 India
18.2.5 Australia
18.2.6 South East Asia (SEA)
18.2.7 Rest of Asia Pacific (APAC)
18.3 Basis Point Share (BPS) Analysis by Country
18.4 Absolute $ Opportunity Assessment by Country
18.5 Market Attractiveness Analysis by Country
18.6 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
18.6.1 Cytotoxicity
18.6.2 Viability
18.6.3 Function
18.6.4 Cell Identification
18.6.5 Differentiation
18.6.6 Apoptosis
18.6.7 Isolation & Purification
18.6.8 Proliferation
18.7 Basis Point Share (BPS) Analysis by Type
18.8 Absolute $ Opportunity Assessment by Type
18.9 Market Attractiveness Analysis by Type
18.10 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
18.10.1 IPSCs
18.11 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
18.12 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
18.13 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
18.14 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
18.14.1 Services
18.14.2 Kits
18.14.3 Flow Cytometers
18.14.4 Cell Imaging Systems
18.14.5 Microelectrode Arrays
18.14.6 Automated Cell Counters
18.15 Basis Point Share (BPS) Analysis by Service
18.16 Absolute $ Opportunity Assessment by Service
18.17 Market Attractiveness Analysis by Service
18.18 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
18.18.1 Orthopaedic & Musculoskeletal Spine Applications
18.18.2 Dermatology
18.18.3 Diabetes
18.18.4 Central Nervous System Applications
18.18.5 Cardiovascular Applications
18.18.6 Drug Discovery & Development
18.18.7 Clinical Research
18.18.8 Oncology
18.19 Basis Point Share (BPS) Analysis by Application
18.20 Absolute $ Opportunity Assessment by Application
18.21 Market Attractiveness Analysis by Application
18.22 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
18.22.1 Mesenchymal Stem Cells MSCs
18.23 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
18.24 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
18.25 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
18.26 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
18.26.1 NSCs
18.27 Basis Point Share (BPS) Analysis by Neural Stem Cells
18.28 Absolute $ Opportunity Assessment by Neural Stem Cells
18.29 Market Attractiveness Analysis by Neural Stem Cells
18.30 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
18.30.1 HESCs
18.31 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
18.32 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
18.33 Market Attractiveness Analysis by Human Embryonic Stem Cells
18.34 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
18.34.1 HSCs
18.35 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
18.36 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
18.37 Market Attractiveness Analysis by Hematopoietic Stem Cells
18.38 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
18.38.1 Biopharmaceutical & Biotechnology Companies
18.38.2 Research Institute
18.39 Basis Point Share (BPS) Analysis by End User
18.40 Absolute $ Opportunity Assessment by End User
18.41 Market Attractiveness Analysis by End User
Chapter 19 Latin America Stem Cell and Gene Therapy Biological Testing Analysis and Forecast
19.1 Introduction
19.2 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Country
19.2.1 Brazil
19.2.2 Mexico
19.2.3 Rest of Latin America (LATAM)
19.3 Basis Point Share (BPS) Analysis by Country
19.4 Absolute $ Opportunity Assessment by Country
19.5 Market Attractiveness Analysis by Country
19.6 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
19.6.1 Cytotoxicity
19.6.2 Viability
19.6.3 Function
19.6.4 Cell Identification
19.6.5 Differentiation
19.6.6 Apoptosis
19.6.7 Isolation & Purification
19.6.8 Proliferation
19.7 Basis Point Share (BPS) Analysis by Type
19.8 Absolute $ Opportunity Assessment by Type
19.9 Market Attractiveness Analysis by Type
19.10 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
19.10.1 IPSCs
19.11 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
19.12 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
19.13 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
19.14 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
19.14.1 Services
19.14.2 Kits
19.14.3 Flow Cytometers
19.14.4 Cell Imaging Systems
19.14.5 Microelectrode Arrays
19.14.6 Automated Cell Counters
19.15 Basis Point Share (BPS) Analysis by Service
19.16 Absolute $ Opportunity Assessment by Service
19.17 Market Attractiveness Analysis by Service
19.18 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
19.18.1 Orthopaedic & Musculoskeletal Spine Applications
19.18.2 Dermatology
19.18.3 Diabetes
19.18.4 Central Nervous System Applications
19.18.5 Cardiovascular Applications
19.18.6 Drug Discovery & Development
19.18.7 Clinical Research
19.18.8 Oncology
19.19 Basis Point Share (BPS) Analysis by Application
19.20 Absolute $ Opportunity Assessment by Application
19.21 Market Attractiveness Analysis by Application
19.22 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
19.22.1 Mesenchymal Stem Cells MSCs
19.23 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
19.24 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
19.25 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
19.26 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
19.26.1 NSCs
19.27 Basis Point Share (BPS) Analysis by Neural Stem Cells
19.28 Absolute $ Opportunity Assessment by Neural Stem Cells
19.29 Market Attractiveness Analysis by Neural Stem Cells
19.30 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
19.30.1 HESCs
19.31 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
19.32 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
19.33 Market Attractiveness Analysis by Human Embryonic Stem Cells
19.34 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
19.34.1 HSCs
19.35 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
19.36 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
19.37 Market Attractiveness Analysis by Hematopoietic Stem Cells
19.38 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
19.38.1 Biopharmaceutical & Biotechnology Companies
19.38.2 Research Institute
19.39 Basis Point Share (BPS) Analysis by End User
19.40 Absolute $ Opportunity Assessment by End User
19.41 Market Attractiveness Analysis by End User
Chapter 20 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Analysis and Forecast
20.1 Introduction
20.2 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Country
20.2.1 Saudi Arabia
20.2.2 South Africa
20.2.3 UAE
20.2.4 Rest of Middle East & Africa (MEA)
20.3 Basis Point Share (BPS) Analysis by Country
20.4 Absolute $ Opportunity Assessment by Country
20.5 Market Attractiveness Analysis by Country
20.6 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
20.6.1 Cytotoxicity
20.6.2 Viability
20.6.3 Function
20.6.4 Cell Identification
20.6.5 Differentiation
20.6.6 Apoptosis
20.6.7 Isolation & Purification
20.6.8 Proliferation
20.7 Basis Point Share (BPS) Analysis by Type
20.8 Absolute $ Opportunity Assessment by Type
20.9 Market Attractiveness Analysis by Type
20.10 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
20.10.1 IPSCs
20.11 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
20.12 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
20.13 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
20.14 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
20.14.1 Services
20.14.2 Kits
20.14.3 Flow Cytometers
20.14.4 Cell Imaging Systems
20.14.5 Microelectrode Arrays
20.14.6 Automated Cell Counters
20.15 Basis Point Share (BPS) Analysis by Service
20.16 Absolute $ Opportunity Assessment by Service
20.17 Market Attractiveness Analysis by Service
20.18 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
20.18.1 Orthopaedic & Musculoskeletal Spine Applications
20.18.2 Dermatology
20.18.3 Diabetes
20.18.4 Central Nervous System Applications
20.18.5 Cardiovascular Applications
20.18.6 Drug Discovery & Development
20.18.7 Clinical Research
20.18.8 Oncology
20.19 Basis Point Share (BPS) Analysis by Application
20.20 Absolute $ Opportunity Assessment by Application
20.21 Market Attractiveness Analysis by Application
20.22 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
20.22.1 Mesenchymal Stem Cells MSCs
20.23 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
20.24 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
20.25 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
20.26 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
20.26.1 NSCs
20.27 Basis Point Share (BPS) Analysis by Neural Stem Cells
20.28 Absolute $ Opportunity Assessment by Neural Stem Cells
20.29 Market Attractiveness Analysis by Neural Stem Cells
20.30 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
20.30.1 HESCs
20.31 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
20.32 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
20.33 Market Attractiveness Analysis by Human Embryonic Stem Cells
20.34 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
20.34.1 HSCs
20.35 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
20.36 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
20.37 Market Attractiveness Analysis by Hematopoietic Stem Cells
20.38 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
20.38.1 Biopharmaceutical & Biotechnology Companies
20.38.2 Research Institute
20.39 Basis Point Share (BPS) Analysis by End User
20.40 Absolute $ Opportunity Assessment by End User
20.41 Market Attractiveness Analysis by End User
Chapter 21 Competition Landscape
21.1 Stem Cell and Gene Therapy Biological Testing Market: Competitive Dashboard
21.2 Global Stem Cell and Gene Therapy Biological Testing Market: Market Share Analysis, 2019
21.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
21.3.1 Mesoblast Ltd
21.3.2 Anterogen Co. Ltd
21.3.3 AlloSource
21.3.4 Smith & Nephew
21.3.5 Promega Corporation
21.3.6 Osiris Therapeutics Inc
21.3.7 Thermo Fisher Scientific
21.3.8 GE Healthcare
21.3.9 Cellular Engineering Technologies
21.3.10 Pharmicell Ltd.
21.3.11 Bio-Rad Laboratories
21.3.12 Merck
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stem Cell and Gene Therapy Biological Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stem Cell and Gene Therapy Biological Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stem Cell and Gene Therapy Biological Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stem Cell and Gene Therapy Biological Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stem Cell and Gene Therapy Biological Testing Market Size & Forecast, 2018-2028
4.5.1 Stem Cell and Gene Therapy Biological Testing Market Size and Y-o-Y Growth
4.5.2 Stem Cell and Gene Therapy Biological Testing Market Absolute $ Opportunity
Chapter 5 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
5.2.1 Cytotoxicity
5.2.2 Viability
5.2.3 Function
5.2.4 Cell Identification
5.2.5 Differentiation
5.2.6 Apoptosis
5.2.7 Isolation & Purification
5.2.8 Proliferation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Induced Pluripotent Stem Cells
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Induced Pluripotent Stem Cells
6.1.2 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
6.1.3 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
6.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
6.2.1 IPSCs
6.3 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
Chapter 7 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Service
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Service
7.1.2 Basis Point Share (BPS) Analysis by Service
7.1.3 Absolute $ Opportunity Assessment by Service
7.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
7.2.1 Services
7.2.2 Kits
7.2.3 Flow Cytometers
7.2.4 Cell Imaging Systems
7.2.5 Microelectrode Arrays
7.2.6 Automated Cell Counters
7.3 Market Attractiveness Analysis by Service
Chapter 8 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Application
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Application
8.1.2 Basis Point Share (BPS) Analysis by Application
8.1.3 Absolute $ Opportunity Assessment by Application
8.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
8.2.1 Orthopaedic & Musculoskeletal Spine Applications
8.2.2 Dermatology
8.2.3 Diabetes
8.2.4 Central Nervous System Applications
8.2.5 Cardiovascular Applications
8.2.6 Drug Discovery & Development
8.2.7 Clinical Research
8.2.8 Oncology
8.3 Market Attractiveness Analysis by Application
Chapter 9 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Cell Type (Mesenchymal Stem Cells
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Cell Type (Mesenchymal Stem Cells
9.1.2 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
9.1.3 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
9.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
9.2.1 Mesenchymal Stem Cells MSCs
9.3 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
Chapter 10 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Neural Stem Cells
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by Neural Stem Cells
10.1.2 Basis Point Share (BPS) Analysis by Neural Stem Cells
10.1.3 Absolute $ Opportunity Assessment by Neural Stem Cells
10.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
10.2.1 NSCs
10.3 Market Attractiveness Analysis by Neural Stem Cells
Chapter 11 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Human Embryonic Stem Cells
11.1 Introduction
11.1.1 Key Market Trends & Growth Opportunities by Human Embryonic Stem Cells
11.1.2 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
11.1.3 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
11.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
11.2.1 HESCs
11.3 Market Attractiveness Analysis by Human Embryonic Stem Cells
Chapter 12 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Hematopoietic Stem Cells
12.1 Introduction
12.1.1 Key Market Trends & Growth Opportunities by Hematopoietic Stem Cells
12.1.2 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
12.1.3 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
12.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
12.2.1 HSCs
12.3 Market Attractiveness Analysis by Hematopoietic Stem Cells
Chapter 13 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by End User
13.1 Introduction
13.1.1 Key Market Trends & Growth Opportunities by End User
13.1.2 Basis Point Share (BPS) Analysis by End User
13.1.3 Absolute $ Opportunity Assessment by End User
13.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
13.2.1 Biopharmaceutical & Biotechnology Companies
13.2.2 Research Institute
13.3 Market Attractiveness Analysis by End User
Chapter 14 Global Stem Cell and Gene Therapy Biological Testing Market Analysis and Forecast by Region
14.1 Introduction
14.1.1 Key Market Trends & Growth Opportunities by Region
14.1.2 Basis Point Share (BPS) Analysis by Region
14.1.3 Absolute $ Opportunity Assessment by Region
14.2 Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Region
14.2.1 North America
14.2.2 Europe
14.2.3 Asia Pacific
14.2.4 Latin America
14.2.5 Middle East & Africa (MEA)
14.3 Market Attractiveness Analysis by Region
Chapter 15 Coronavirus Disease (COVID-19) Impact
15.1 Introduction
15.2 Current & Future Impact Analysis
15.3 Economic Impact Analysis
15.4 Government Policies
15.5 Investment Scenario
Chapter 16 North America Stem Cell and Gene Therapy Biological Testing Analysis and Forecast
16.1 Introduction
16.2 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Country
16.2.1 U.S.
16.2.2 Canada
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
16.6.1 Cytotoxicity
16.6.2 Viability
16.6.3 Function
16.6.4 Cell Identification
16.6.5 Differentiation
16.6.6 Apoptosis
16.6.7 Isolation & Purification
16.6.8 Proliferation
16.7 Basis Point Share (BPS) Analysis by Type
16.8 Absolute $ Opportunity Assessment by Type
16.9 Market Attractiveness Analysis by Type
16.10 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
16.10.1 IPSCs
16.11 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
16.12 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
16.13 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
16.14 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
16.14.1 Services
16.14.2 Kits
16.14.3 Flow Cytometers
16.14.4 Cell Imaging Systems
16.14.5 Microelectrode Arrays
16.14.6 Automated Cell Counters
16.15 Basis Point Share (BPS) Analysis by Service
16.16 Absolute $ Opportunity Assessment by Service
16.17 Market Attractiveness Analysis by Service
16.18 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
16.18.1 Orthopaedic & Musculoskeletal Spine Applications
16.18.2 Dermatology
16.18.3 Diabetes
16.18.4 Central Nervous System Applications
16.18.5 Cardiovascular Applications
16.18.6 Drug Discovery & Development
16.18.7 Clinical Research
16.18.8 Oncology
16.19 Basis Point Share (BPS) Analysis by Application
16.20 Absolute $ Opportunity Assessment by Application
16.21 Market Attractiveness Analysis by Application
16.22 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
16.22.1 Mesenchymal Stem Cells MSCs
16.23 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
16.24 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
16.25 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
16.26 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
16.26.1 NSCs
16.27 Basis Point Share (BPS) Analysis by Neural Stem Cells
16.28 Absolute $ Opportunity Assessment by Neural Stem Cells
16.29 Market Attractiveness Analysis by Neural Stem Cells
16.30 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
16.30.1 HESCs
16.31 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
16.32 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
16.33 Market Attractiveness Analysis by Human Embryonic Stem Cells
16.34 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
16.34.1 HSCs
16.35 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
16.36 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
16.37 Market Attractiveness Analysis by Hematopoietic Stem Cells
16.38 North America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
16.38.1 Biopharmaceutical & Biotechnology Companies
16.38.2 Research Institute
16.39 Basis Point Share (BPS) Analysis by End User
16.40 Absolute $ Opportunity Assessment by End User
16.41 Market Attractiveness Analysis by End User
Chapter 17 Europe Stem Cell and Gene Therapy Biological Testing Analysis and Forecast
17.1 Introduction
17.2 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Country
17.2.1 Germany
17.2.2 France
17.2.3 Italy
17.2.4 U.K.
17.2.5 Spain
17.2.6 Russia
17.2.7 Rest of Europe
17.3 Basis Point Share (BPS) Analysis by Country
17.4 Absolute $ Opportunity Assessment by Country
17.5 Market Attractiveness Analysis by Country
17.6 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
17.6.1 Cytotoxicity
17.6.2 Viability
17.6.3 Function
17.6.4 Cell Identification
17.6.5 Differentiation
17.6.6 Apoptosis
17.6.7 Isolation & Purification
17.6.8 Proliferation
17.7 Basis Point Share (BPS) Analysis by Type
17.8 Absolute $ Opportunity Assessment by Type
17.9 Market Attractiveness Analysis by Type
17.10 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
17.10.1 IPSCs
17.11 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
17.12 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
17.13 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
17.14 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
17.14.1 Services
17.14.2 Kits
17.14.3 Flow Cytometers
17.14.4 Cell Imaging Systems
17.14.5 Microelectrode Arrays
17.14.6 Automated Cell Counters
17.15 Basis Point Share (BPS) Analysis by Service
17.16 Absolute $ Opportunity Assessment by Service
17.17 Market Attractiveness Analysis by Service
17.18 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
17.18.1 Orthopaedic & Musculoskeletal Spine Applications
17.18.2 Dermatology
17.18.3 Diabetes
17.18.4 Central Nervous System Applications
17.18.5 Cardiovascular Applications
17.18.6 Drug Discovery & Development
17.18.7 Clinical Research
17.18.8 Oncology
17.19 Basis Point Share (BPS) Analysis by Application
17.20 Absolute $ Opportunity Assessment by Application
17.21 Market Attractiveness Analysis by Application
17.22 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
17.22.1 Mesenchymal Stem Cells MSCs
17.23 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
17.24 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
17.25 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
17.26 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
17.26.1 NSCs
17.27 Basis Point Share (BPS) Analysis by Neural Stem Cells
17.28 Absolute $ Opportunity Assessment by Neural Stem Cells
17.29 Market Attractiveness Analysis by Neural Stem Cells
17.30 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
17.30.1 HESCs
17.31 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
17.32 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
17.33 Market Attractiveness Analysis by Human Embryonic Stem Cells
17.34 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
17.34.1 HSCs
17.35 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
17.36 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
17.37 Market Attractiveness Analysis by Hematopoietic Stem Cells
17.38 Europe Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
17.38.1 Biopharmaceutical & Biotechnology Companies
17.38.2 Research Institute
17.39 Basis Point Share (BPS) Analysis by End User
17.40 Absolute $ Opportunity Assessment by End User
17.41 Market Attractiveness Analysis by End User
Chapter 18 Asia Pacific Stem Cell and Gene Therapy Biological Testing Analysis and Forecast
18.1 Introduction
18.2 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Country
18.2.1 China
18.2.2 Japan
18.2.3 South Korea
18.2.4 India
18.2.5 Australia
18.2.6 South East Asia (SEA)
18.2.7 Rest of Asia Pacific (APAC)
18.3 Basis Point Share (BPS) Analysis by Country
18.4 Absolute $ Opportunity Assessment by Country
18.5 Market Attractiveness Analysis by Country
18.6 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
18.6.1 Cytotoxicity
18.6.2 Viability
18.6.3 Function
18.6.4 Cell Identification
18.6.5 Differentiation
18.6.6 Apoptosis
18.6.7 Isolation & Purification
18.6.8 Proliferation
18.7 Basis Point Share (BPS) Analysis by Type
18.8 Absolute $ Opportunity Assessment by Type
18.9 Market Attractiveness Analysis by Type
18.10 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
18.10.1 IPSCs
18.11 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
18.12 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
18.13 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
18.14 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
18.14.1 Services
18.14.2 Kits
18.14.3 Flow Cytometers
18.14.4 Cell Imaging Systems
18.14.5 Microelectrode Arrays
18.14.6 Automated Cell Counters
18.15 Basis Point Share (BPS) Analysis by Service
18.16 Absolute $ Opportunity Assessment by Service
18.17 Market Attractiveness Analysis by Service
18.18 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
18.18.1 Orthopaedic & Musculoskeletal Spine Applications
18.18.2 Dermatology
18.18.3 Diabetes
18.18.4 Central Nervous System Applications
18.18.5 Cardiovascular Applications
18.18.6 Drug Discovery & Development
18.18.7 Clinical Research
18.18.8 Oncology
18.19 Basis Point Share (BPS) Analysis by Application
18.20 Absolute $ Opportunity Assessment by Application
18.21 Market Attractiveness Analysis by Application
18.22 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
18.22.1 Mesenchymal Stem Cells MSCs
18.23 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
18.24 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
18.25 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
18.26 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
18.26.1 NSCs
18.27 Basis Point Share (BPS) Analysis by Neural Stem Cells
18.28 Absolute $ Opportunity Assessment by Neural Stem Cells
18.29 Market Attractiveness Analysis by Neural Stem Cells
18.30 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
18.30.1 HESCs
18.31 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
18.32 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
18.33 Market Attractiveness Analysis by Human Embryonic Stem Cells
18.34 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
18.34.1 HSCs
18.35 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
18.36 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
18.37 Market Attractiveness Analysis by Hematopoietic Stem Cells
18.38 Asia Pacific Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
18.38.1 Biopharmaceutical & Biotechnology Companies
18.38.2 Research Institute
18.39 Basis Point Share (BPS) Analysis by End User
18.40 Absolute $ Opportunity Assessment by End User
18.41 Market Attractiveness Analysis by End User
Chapter 19 Latin America Stem Cell and Gene Therapy Biological Testing Analysis and Forecast
19.1 Introduction
19.2 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Country
19.2.1 Brazil
19.2.2 Mexico
19.2.3 Rest of Latin America (LATAM)
19.3 Basis Point Share (BPS) Analysis by Country
19.4 Absolute $ Opportunity Assessment by Country
19.5 Market Attractiveness Analysis by Country
19.6 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
19.6.1 Cytotoxicity
19.6.2 Viability
19.6.3 Function
19.6.4 Cell Identification
19.6.5 Differentiation
19.6.6 Apoptosis
19.6.7 Isolation & Purification
19.6.8 Proliferation
19.7 Basis Point Share (BPS) Analysis by Type
19.8 Absolute $ Opportunity Assessment by Type
19.9 Market Attractiveness Analysis by Type
19.10 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
19.10.1 IPSCs
19.11 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
19.12 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
19.13 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
19.14 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
19.14.1 Services
19.14.2 Kits
19.14.3 Flow Cytometers
19.14.4 Cell Imaging Systems
19.14.5 Microelectrode Arrays
19.14.6 Automated Cell Counters
19.15 Basis Point Share (BPS) Analysis by Service
19.16 Absolute $ Opportunity Assessment by Service
19.17 Market Attractiveness Analysis by Service
19.18 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
19.18.1 Orthopaedic & Musculoskeletal Spine Applications
19.18.2 Dermatology
19.18.3 Diabetes
19.18.4 Central Nervous System Applications
19.18.5 Cardiovascular Applications
19.18.6 Drug Discovery & Development
19.18.7 Clinical Research
19.18.8 Oncology
19.19 Basis Point Share (BPS) Analysis by Application
19.20 Absolute $ Opportunity Assessment by Application
19.21 Market Attractiveness Analysis by Application
19.22 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
19.22.1 Mesenchymal Stem Cells MSCs
19.23 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
19.24 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
19.25 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
19.26 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
19.26.1 NSCs
19.27 Basis Point Share (BPS) Analysis by Neural Stem Cells
19.28 Absolute $ Opportunity Assessment by Neural Stem Cells
19.29 Market Attractiveness Analysis by Neural Stem Cells
19.30 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
19.30.1 HESCs
19.31 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
19.32 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
19.33 Market Attractiveness Analysis by Human Embryonic Stem Cells
19.34 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
19.34.1 HSCs
19.35 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
19.36 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
19.37 Market Attractiveness Analysis by Hematopoietic Stem Cells
19.38 Latin America Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
19.38.1 Biopharmaceutical & Biotechnology Companies
19.38.2 Research Institute
19.39 Basis Point Share (BPS) Analysis by End User
19.40 Absolute $ Opportunity Assessment by End User
19.41 Market Attractiveness Analysis by End User
Chapter 20 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Analysis and Forecast
20.1 Introduction
20.2 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Country
20.2.1 Saudi Arabia
20.2.2 South Africa
20.2.3 UAE
20.2.4 Rest of Middle East & Africa (MEA)
20.3 Basis Point Share (BPS) Analysis by Country
20.4 Absolute $ Opportunity Assessment by Country
20.5 Market Attractiveness Analysis by Country
20.6 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Type
20.6.1 Cytotoxicity
20.6.2 Viability
20.6.3 Function
20.6.4 Cell Identification
20.6.5 Differentiation
20.6.6 Apoptosis
20.6.7 Isolation & Purification
20.6.8 Proliferation
20.7 Basis Point Share (BPS) Analysis by Type
20.8 Absolute $ Opportunity Assessment by Type
20.9 Market Attractiveness Analysis by Type
20.10 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Induced Pluripotent Stem Cells
20.10.1 IPSCs
20.11 Basis Point Share (BPS) Analysis by Induced Pluripotent Stem Cells
20.12 Absolute $ Opportunity Assessment by Induced Pluripotent Stem Cells
20.13 Market Attractiveness Analysis by Induced Pluripotent Stem Cells
20.14 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Service
20.14.1 Services
20.14.2 Kits
20.14.3 Flow Cytometers
20.14.4 Cell Imaging Systems
20.14.5 Microelectrode Arrays
20.14.6 Automated Cell Counters
20.15 Basis Point Share (BPS) Analysis by Service
20.16 Absolute $ Opportunity Assessment by Service
20.17 Market Attractiveness Analysis by Service
20.18 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Application
20.18.1 Orthopaedic & Musculoskeletal Spine Applications
20.18.2 Dermatology
20.18.3 Diabetes
20.18.4 Central Nervous System Applications
20.18.5 Cardiovascular Applications
20.18.6 Drug Discovery & Development
20.18.7 Clinical Research
20.18.8 Oncology
20.19 Basis Point Share (BPS) Analysis by Application
20.20 Absolute $ Opportunity Assessment by Application
20.21 Market Attractiveness Analysis by Application
20.22 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Cell Type (Mesenchymal Stem Cells
20.22.1 Mesenchymal Stem Cells MSCs
20.23 Basis Point Share (BPS) Analysis by Cell Type (Mesenchymal Stem Cells
20.24 Absolute $ Opportunity Assessment by Cell Type (Mesenchymal Stem Cells
20.25 Market Attractiveness Analysis by Cell Type (Mesenchymal Stem Cells
20.26 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Neural Stem Cells
20.26.1 NSCs
20.27 Basis Point Share (BPS) Analysis by Neural Stem Cells
20.28 Absolute $ Opportunity Assessment by Neural Stem Cells
20.29 Market Attractiveness Analysis by Neural Stem Cells
20.30 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Human Embryonic Stem Cells
20.30.1 HESCs
20.31 Basis Point Share (BPS) Analysis by Human Embryonic Stem Cells
20.32 Absolute $ Opportunity Assessment by Human Embryonic Stem Cells
20.33 Market Attractiveness Analysis by Human Embryonic Stem Cells
20.34 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by Hematopoietic Stem Cells
20.34.1 HSCs
20.35 Basis Point Share (BPS) Analysis by Hematopoietic Stem Cells
20.36 Absolute $ Opportunity Assessment by Hematopoietic Stem Cells
20.37 Market Attractiveness Analysis by Hematopoietic Stem Cells
20.38 Middle East & Africa (MEA) Stem Cell and Gene Therapy Biological Testing Market Size Forecast by End User
20.38.1 Biopharmaceutical & Biotechnology Companies
20.38.2 Research Institute
20.39 Basis Point Share (BPS) Analysis by End User
20.40 Absolute $ Opportunity Assessment by End User
20.41 Market Attractiveness Analysis by End User
Chapter 21 Competition Landscape
21.1 Stem Cell and Gene Therapy Biological Testing Market: Competitive Dashboard
21.2 Global Stem Cell and Gene Therapy Biological Testing Market: Market Share Analysis, 2019
21.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
21.3.1 Mesoblast Ltd
21.3.2 Anterogen Co. Ltd
21.3.3 AlloSource
21.3.4 Smith & Nephew
21.3.5 Promega Corporation
21.3.6 Osiris Therapeutics Inc
21.3.7 Thermo Fisher Scientific
21.3.8 GE Healthcare
21.3.9 Cellular Engineering Technologies
21.3.10 Pharmicell Ltd.
21.3.11 Bio-Rad Laboratories
21.3.12 Merck
Segments Covered in the Report
The global Stem Cell and Gene Therapy Biological Testing market has been segmented based on
By Type
The global Stem Cell and Gene Therapy Biological Testing market has been segmented based on
By Type
- Cytotoxicity
- Viability
- Function
- Cell Identification
- Differentiation
- Apoptosis
- Isolation & Purification
- Proliferation
- IPSCs
- Services
- Kits
- Flow Cytometers
- Cell Imaging Systems
- Microelectrode Arrays
- Automated Cell Counters
- Orthopaedic & Musculoskeletal Spine Applications
- Dermatology
- Diabetes
- Central Nervous System Applications
- Cardiovascular Applications
- Drug Discovery & Development
- Clinical Research
- Oncology
- Mesenchymal Stem Cells MSCs
- NSCs
- HESCs
- HSCs
- Biopharmaceutical & Biotechnology Companies
- Research Institute
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Mesoblast Ltd
- Anterogen Co. Ltd
- AlloSource
- Smith & Nephew
- Promega Corporation
- Osiris Therapeutics Inc
- Thermo Fisher Scientific
- GE Healthcare
- Cellular Engineering Technologies
- Pharmicell Ltd.
- Bio-Rad Laboratories
- Merck
Our Clients
Related Reports
Some other reports from this category!
